Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin for abnormal peripheral perfusion in circulatory shock
2013-002189-38Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nitroglycerin in Shock, sponsored by Erasmus MC. Primary endpoint: Improvement in peripheral perfusion. Started Apr 2015; status: active.
02
Drugs
nitroglycerin
03
Conditions
Shock
Beyond the preview
Go deeper on 2013-002189-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002189-38.